Trials / Completed
CompletedNCT02951351
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
Detailed description
To ensure the extra drop does not interfere with antisepsis, conjunctival cultures will be obtained from patients undergoing intravitreal injection before and after the application of the extra eye drop. Patients will be randomized to undergo additional topical analgesia during intravitreal injection vs. the standard amount of topical analgesia. Cultures of the eyelid/conjunctiva will be taken to ensure that the additional topical analgesia does not interfere with antisepsis.
Conditions
- Age-related Macular Degeneration
- Diabetic Macular Edema
- Injection Site
- Injection Site Infection
- Pain, Postoperative
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proparacaine | Extra proparacaine will be applied to the conjunctival surface to determine its role in patient experience. |
| PROCEDURE | Conjunctival culture | Conjunctival cultures will be performed to ensure that the intervention does not interfere with antisepsis. |
Timeline
- Start date
- 2016-10-12
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2016-11-01
- Last updated
- 2023-04-12
- Results posted
- 2019-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02951351. Inclusion in this directory is not an endorsement.